Furthermore, in our previous study, we demonstrated that DNA methylation of CLDN6 enhanced breast cancer cell migration and invasion by recruiting methyl CpG binding protein 2 (MeCP2) and deacetylating histone 3 acetylation (H3Ac) and histone 4 acetylation (H4Ac) [12]. This evidence concerns the gene CLDN6 and breast cancer.